Subscribe for free to the America First Report newsletter.
Activists protest for transgender rights. / IMAGE: Fox5 via YouTube Drug manufacturers who make puberty blockers are increasingly refusing to conduct safety tests, presumably for political reasons, the Daily Wire reported .
In particular, manufacturers Endo International plc and AbbVie Inc have declined to conduct safety tests on the puberty blocking drug Lupron.
According to the report, from 2017 to 2021, 17,683 of the 121,882 children ages 6 to 17 who were “diagnosed” with “gender dysphoria” were prescribed life-altering hormones or puberty blockers.
Dr. Brad Miller, division director of pediatric endocrinology at the University of Minnesota Medical School and M Health Masonic Children’s Hospital said that he, along with several colleagues, looked into the matter.“They would say it would cost a lot of money to get approval,” Miller said of the drug manufacturers’ refusal. “And they were not interested in going there because (transgender treatment) was a political hot potato.”According to the […]
Excerpt Sourced From: headlineusa.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
